Loading...
Indivior Pharmaceuticals Inc
INDV•NASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$34.44
$0.00(0.00%)
U.S. Market is Open • 12:49Indivior Pharmaceuticals Inc (INDV) AI-Powered Stock Analysis
See how Indivior Pharmaceuticals Inc scores across key metrics like financial growth, valuation, and market position using AI-driven evaluation.
Model Information
The AI Stock Analysis Model is provided for informational purposes only and should not be considered financial advice. We are continously improving this model to increase accuracy and performance.Read our Full DisclaimerIndivior Pharmaceuticals Inc (INDV) Stock Overall Grade
Indivior Pharmaceuticals Inc’s grade based on a comprehensive AI analysis of financial metrics, growth potential, and market position.
Z
Grade Breakdown by Metric
See how each financial and market factor contributes to Indivior Pharmaceuticals Inc's overall stock rating.
Forecast
AScore
80/100Financial Growth
BScore
60/100Fundamental Growth
C+Score
57/100Key Ratios
BScore
65/100Sector Comparison
A+Score
100/100Industry Comparison
C+Score
50/100S&P 500 Benchmark
A+Score
95/100Analyst Consensus
B+Score
75/100Indivior Pharmaceuticals Inc (INDV) AI-Powered Stock Analysis
This asset demonstrates Good performance with an overall Forecast Score of 80/100 (A), reflecting high confidence in its potential. Financial Growth (60/100, B) and Fundamental Growth (57/100, C+) highlight its stability, while Key Ratios (65/100, B) and Sector Comparison (100/100, A+) indicate solid positioning. Compared to broader benchmarks like the S&P 500 (95/100, A+), it shows competitive strength. Analyst Consensus (75/100,B+) suggests High divergence in outlook.Component Analysis Explained
Understand the key factors behind each Indivior Pharmaceuticals Inc stock grade, including financials, comparisons, and forecasts.